Yu Wing Tak Wendy Buys Shares of NAGE
Yu Wing Tak Wendy acquired 31,746 shares of NAGE, signaling insider confidence.
Key Points
- Yu Wing Tak Wendy purchased 31,746 shares of NAGE on June 24, 2026.
- NAGE shares traded at $3.42 on Saturday, showing investor interest.
- Analysts from HC Wainwright & Co. and Canaccord Genuity maintain a 'buy' rating with targets up to $11.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Yu Wing Tak Wendy acquired 31,746 shares of NAGE on June 24, 2026. This insider transaction did not involve a planned purchase, indicating a direct investment decision at the time.
Insider Buying and Selling at Niagen Bioscience, Inc.
Several insiders, including Frank Jaksch Jr., Ng Wang Yu Gary, and others, each bought 31,746 shares of NAGE on June 24, 2026. These purchases were not part of a pre-arranged trading plan, suggesting confidence in the company's future.
Other Institutional Activity in NAGE
BlackRock, Inc. reduced its holdings in NAGE by 204,090 shares, leaving it with 3,871,619 shares valued at about $17,073,839. SteelPeak Wealth, LLC opened a new position with 3,373,000 shares worth approximately $14,874,930. Arrowstreet Capital, Limited Partnership increased its stake by 761,685 shares, now holding 2,378,437 shares valued at $10,488,907. Vanguard Capital Management LLC also opened a new position with 2,149,277 shares, valued at $9,478,312. Meanwhile, Tieton Capital Management, LLC added 384,062 shares, bringing its total to 2,029,155 shares valued at $8,949,000.
Niagen Bioscience, Inc. Stock Up 4.0%
On Saturday, shares of NAGE traded at $3.42. The company's recent trading activity reflects ongoing interest, with significant institutional movements and insider purchases.
$NAGE stock price
Daily closing prices, year to date. Not investment advice.
Analysts Set New Price Targets
On May 11, 2026, HC Wainwright & Co. maintained a 'buy' rating for NAGE with a price target of $11. Similarly, Canaccord Genuity has consistently maintained a 'buy' rating, with the most recent target set at $10 on May 5, 2026. The consensus among analysts remains positive, with the stock seen as a buy.
Bottom Line
Insider buying activity at NAGE, including Yu Wing Tak Wendy's recent acquisition, suggests confidence in the company's prospects. Institutional investors also made significant moves, with some opening new positions. Analysts continue to maintain a positive outlook, supporting the stock's potential for growth. However, it's important to remember that insider and institutional activities are not definitive indicators of future performance.
Get Niagen Bioscience, Inc. alerts
New 13F filings, insider trades, and analyst moves on $NAGE, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.